About Samuel Lee
Samuel Lee is a president and chief business officer, director at Eikonoklastes Therapeutics.
Form D filings also name Samuel Lee as a director at Invirsa and XII Medical.
Samuel Lee first appears on SEC filings in 2020.
Experience
This experience comes from Samuel Lee's profile and from SEC filings. For roles taken from filings, the years are when the filings name Samuel Lee in the role, so the role may have started earlier or lasted longer.
AI
American Gene Technologies® International Inc. Current
Angel Investor
2022 – Present
CA
Copy.ai Current
Angel Investor
2021 – Present
VB
Vincere Biosciences Current
Angel Investor
2021 – Present
SS
Swift Solar Current
Angel Investor
2020 – Present
Eikonoklastes Therapeutics, Inc. Current
President and Chief Business Officer, director
Co-Founder, President, and Chief Business Officer (2019 – Present)
2019 – Present · Cincinnati, OH
Develops gene therapies for people with ALS and other neurodegenerative diseases.
BE
Beacons Current
Angel Investor
2019 – Present
PB
Pragma Bio Current
Angel Investor
2019 – Present
NT
Nanodetection Technology Current
Board Member
2018 – Present
CU
CincyTech USA
Executive In Residence
2016 – 2023
CB
Circularis Biotechnologies
Angel Investor
2021 – 2022
BI
Blue Water Vaccines Inc.
Board Member
2019 – 2022
SB
Standard Bariatrics
Board Observer
2018 – 2022
OC
Oculii
Angel Investor
2021
CE
Command E
Angel Investor
2020 – 2021
MT
Myoneuxs Therapeutics
Board Observer
2017 – 2019
CC
Cincinnati Children's Hospital Medical Center
Postdoctoral Research Fellow
2016 – 2017
DO
Doximity
Physician Panelist
2015 – 2017
AB
Abbott
MD Intern
2013
Key Colleagues at Startups
The people Samuel Lee works with at each company, as listed on that company's latest Form D.
Eikonoklastes Therapeutics, Inc. · Form D/A, Oct 6, 2026
Bruce Halpryn
Chairman and Chief Executive Officer
KM
Kenneth Morand
Partner, CincyTech and director
TF
Thomas Finn
Director
RJ
Robert Johnson
CEO, Kesmalea Therapeutics and director
JN
Joseph Nolan
CEO, Jaguar Gene Therapy and director
Invirsa, Inc. · Form D, Nov 29, 2023
WE
Wayne Embree
Director
TW
Tim Willis
Director
FV
Faith Voinovich
Director
RS
Robert Shalwitz
President and director
XII Medical, Inc. · Form D, Jan 7, 2021
AS
Akhil Saklecha
Executive officer and director
BP
Benjamin Pless
Director
JN
Josh Nickols
Executive officer
JR
Joseph Rich
Executive officer